EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis

Gianmaria Salvio iD, Alessandro Ciarloni, Nairus Aboud, Nicola Ambo, Monia Bordoni, Beatrice Lucchetti, Marianna Martino, Michele Perrone, Matteo Gasparroni, Giancarlo Balercia, Giorgio Arnaldi iD

The Journal of Clinical Endocrinology & Metabolism · 17.03.2026 · 111 (4) · 1187-1202

DOI: 10.1210/clinem/dgaf681 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 23.12.2025. Verfasst von Gianmaria Salvio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona 60126, Italy. Hauptthemen laut MEDLINE: Cushing Syndrome, Dyslipidemias. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cushing syndrome (CS) is a clinical condition caused by increased plasma cortisol levels and characterized by high cardiovascular mortality. Among the metabolic effects of CS and its treatment, glycemic disturbances have been investigated in depth, while data on dyslipidemia is still lacking.

Objectives

Our study aims at evaluating the effects of CS treatment on serum lipid levels. Materials and methods A literature search was conducted using PubMed, Scopus, and EMBASE databases to investigate the effects of CS treatment on serum total cholesterol (TC), low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides. Before-after analysis and subgroup analysis were performed.

Results

Twenty-nine observational or interventional studies (51.7% of good quality) were included in the quantitative analysis. Treatment of CS led to clinically and statistically significant decrease in serum TC (mean difference [MD] −26.49; 95% CI, −29.95 to −23.04; P < .00001), low-density lipoprotein cholesterol (MD −18.44; 95% CI, −21.30 to −15.57; P < .00001), and triglycerides levels (MD −17.77; 95% CI, −22.70 to −12.84; P < .00001), with no significant changes in high-density lipoprotein cholesterol levels (MD −2.34; 95% CI, −6.96 to 2.28; P = .32). Subgroup analysis showed greater decrease in TC levels in subjects with adrenal hypercortisolism, in those treated with steroidogenesis inhibitors, and in those with treatment duration ≥12 months. In addition, CS treatment significantly decreased blood glucose levels, body mass index, waist circumference, and insulin resistance index.

Conclusion

Our study demonstrates a significant improvement in serum lipid levels after treatment of CS. Because the cardiovascular complications of hypercortisolism depend on several factors, further studies are needed to determine whether this directly translates into an adequate reduction in the risk of major cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cushing SyndromeDyslipidemiasHumansHydrocortisoneLipids

Stichwörter der Autor:innen

adrenalectomycholesterolhigh-density lipoproteinketoconazolelevoketoconazolelow-density lipoproteinmifepristoneosilodrostatpasireotidesteroidogenesis inhibitorstranssphenoidal neurosurgerytriglycerides

Substanzen

HydrocortisoneLipids

Autor:innen und Institutionen

  • Endocrinology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona 60126, Italy.
  • Section of Endocrinology, PROMISE, University of Palermo, Palermo 90127, Italy.

ORCID-Profile: Gianmaria Salvio, Giorgio Arnaldi

Zitieren

APA

Salvio, G., Ciarloni, A., Aboud, N., Ambo, N., Bordoni, M., Lucchetti, B., Martino, M., Perrone, M., Gasparroni, M., Balercia, G., & Arnaldi, G. (2026). The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 111(4), 1187-1202. https://doi.org/10.1210/clinem/dgaf681

Vancouver

Salvio G, Ciarloni A, Aboud N, Ambo N, Bordoni M, Lucchetti B, et al. The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2026;111(4):1187-1202. doi:10.1210/clinem/dgaf681

BibTeX
@article{Salvio2026,
  author = {Salvio, Gianmaria and Ciarloni, Alessandro and Aboud, Nairus and Ambo, Nicola and Bordoni, Monia and Lucchetti, Beatrice and Martino, Marianna and Perrone, Michele and Gasparroni, Matteo and Balercia, Giancarlo and Arnaldi, Giorgio},
  title = {The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {4},
  pages = {1187--1202},
  doi = {10.1210/clinem/dgaf681}
}
Kostenlos starten →